Presentation
4 March 2022 Highly sensitive and specific SARS-CoV-2 serological assay using a magnetic modulation biosensing system
Shira Avivi Mintz, Yaniv Lustig, Victoria Indenbaum, Eli Schwartz, Amos Danielli
Author Affiliations +
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to pose a global public health threat. Effective and rapid serological assays are needed to provide valuable information about acute and past viral infections. Using the receptor-binding domain of the SARS-CoV-2 spike protein 1 antigen and a highly sensitive detection technology, termed magnetic modulation biosensing (MMB), we demonstrate a quantitative and rapid SARS-CoV-2 IgG antibody test with high sensitivity and specificity compared with the gold standard ELISA test. The improved analytical and clinical sensitivity of the MMB-based assay can help clinical laboratories provide critical information in a timely manner and monitor the spread of the disease.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shira Avivi Mintz, Yaniv Lustig, Victoria Indenbaum, Eli Schwartz, and Amos Danielli "Highly sensitive and specific SARS-CoV-2 serological assay using a magnetic modulation biosensing system", Proc. SPIE PC11979, Frontiers in Biological Detection: From Nanosensors to Systems XIV, PC1197906 (4 March 2022); https://doi.org/10.1117/12.2613433
Advertisement
Advertisement
KEYWORDS
Biosensing

Magnetism

Modulation

Gold

Magnetic sensors

Proteins

Standards development

Back to Top